Rio Verde
Ask VT AI
View News Summary
- Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
- NatWest reports strong Q3 results, raising guidance and hitting new highs as it benefits from higher interest rates and loan growth.
- Nvidia becomes the first company to reach a $5 trillion market valuation, driven by record demand for its AI processors and dominating the GPU market for large-scale AI workloads.
20 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Eli Lilly to acquire Adverum Biotechnologies in a deal worth up to $12.47 per share, with a focus on Adverum's gene therapy candidate Ixo-vec.
- NatWest reports strong Q3 results, raising guidance and hitting new highs as it benefits from higher interest rates and loan growth.
- Nvidia becomes the first company to reach a $5 trillion market valuation, driven by record demand for its AI processors and dominating the GPU market for large-scale AI workloads.
20 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Rio Verde
News from Rio Verde
